Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Two Different Doses of RAD-001 (Everolimus) as Neo-Adjuvant Therapy in Patients With Localized Prostate Cancer

NCT00526591 is registered in ClinicalTrials.gov with Jorge A. Garcia, MD as lead sponsor.

NCT NCT00526591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00526591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Two Different Doses of RAD-001 (Everolimus) as Neo-Adjuvant Therapy in Patients With Localized Prostate Cancer
Lead sponsor
Jorge A. Garcia, MD
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2007
Completion date
August 31, 2011
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer